ACADEMIC TRAINING

- Bachelor's degree in Health Biology, Universidad de Navarra.

- Graduated in Medicine and Surgery, Universidad de Zaragoza.

- PhD in Molecular and Cellular Biology, Universidad de Navarra.

- Medical Oncology Specialist, Hospital Universitario Fundación Jiménez Díaz

- Different postgraduate Master's degrees in: Clinical Genetics, Healthcare Management, Thoracic Tumors, Digestive Tumors, Central Nervous System Tumors,...

- Associate professor at various universities: Universidad Francisco de Vitoria, Universidad Complutense de Madrid, Universidad a Distancia de Madrid.

EXPERIENCE

- More than 20 years of experience.

Specialization

- Central Nervous System (CNS) Tumors: Glioblastoma, Other high- and low-grade gliomas, Brain metastases, Leptomeningeal disease, other CNS tumors.

- Thoracic Tumors: Lung cancer.

- Genitourinary Tumors: Kidney cancer, Lung cancer Bladder cancer, Prostate cancer, testicular cancer, penile cancer.

- Endocrine and Neuroendocrine tumors.

- Digestive system tumors.

- Tumors of other anatomical regions.

- Genomic analysis and precision oncology. Targeted therapy.

- Genetic counseling and cancer predisposition syndromes.

- Clinical trials and early development of new drugs.

RESEARCH

- A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy. 2022; J Clin Med.

- The Clinical significance of PIWIL3 and PIWIL4 expression in Pancreatic cancer. 2020; J Clin Med.

- KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study. 1, 2020; Cells

- Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations. Oct 1, 2015; BMC Genomics

- LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. Sep 1, 2013; British Journal of Haematology